de Vries EG - Search Results

1

Characterization of three small cell lung cancer cell lines established from one patient during longitudinal follow-up.

Berendsen HH, de Leij L, de Vries EG, Mesander G, Mulder NH, de Jong B, Buys CH, Postmus PE, Poppema S, Sluiter HJ, et al. Berendsen HH, et al. Among authors: de leij l, de jong b, de vries eg. Cancer Res. 1988 Dec 1;48(23):6891-9. Cancer Res. 1988. PMID: 2846164

2

Mitoxantrone resistance in a small cell lung cancer cell line is associated with ABCA2 upregulation.

Boonstra R, Timmer-Bosscha H, van Echten-Arends J, van der Kolk DM, van den Berg A, de Jong B, Tew KD, Poppema S, de Vries EG. Boonstra R, et al. Among authors: de jong b, de vries eg. Br J Cancer. 2004 Jun 14;90(12):2411-7. doi: 10.1038/sj.bjc.6601863. Br J Cancer. 2004. PMID: 15150577 Free PMC article.

3

Increased sensitivity of an adriamycin-resistant human small cell lung carcinoma cell line to mitochondrial inhibitors.

de Jong S, Holtrop M, de Vries H, de Vries EG, Mulder NH. de Jong S, et al. Among authors: de vries h, de vries eg. Biochem Biophys Res Commun. 1992 Jan 31;182(2):877-85. doi: 10.1016/0006-291x(92)91814-7. Biochem Biophys Res Commun. 1992. PMID: 1310401

4

In vitro response of human small-cell lung-cancer cell lines to chemotherapeutic drugs; no correlation with clinical data.

Smit EF, de Vries EG, Timmer-Bosscha H, de Leij LF, Oosterhuis JW, Scheper RJ, Weening JJ, Postmus PE, Mulder NH. Smit EF, et al. Among authors: de vries eg, de leij lf. Int J Cancer. 1992 Apr 22;51(1):72-8. doi: 10.1002/ijc.2910510115. Int J Cancer. 1992. PMID: 1314232

5

Relationship of cellular glutathione to the cytotoxicity and resistance of seven platinum compounds.

Meijer C, Mulder NH, Timmer-Bosscha H, Sluiter WJ, Meersma GJ, de Vries EG. Meijer C, et al. Among authors: de vries eg. Cancer Res. 1992 Dec 15;52(24):6885-9. Cancer Res. 1992. PMID: 1458477

6

Lack of cross-resistance to fostriecin in a human small-cell lung carcinoma cell line showing topoisomerase II-related drug resistance.

de Jong S, Zijlstra JG, Mulder NH, de Vries EG. de Jong S, et al. Among authors: de vries eg. Cancer Chemother Pharmacol. 1991;28(6):461-4. doi: 10.1007/BF00685823. Cancer Chemother Pharmacol. 1991. PMID: 1657425

7

NMR spectroscopy analysis of phosphorus metabolites and the effect of adriamycin on these metabolite levels in an adriamycin-sensitive and -resistant human small cell lung carcinoma cell line.

de Jong S, Mulder NH, de Vries EG, Robillard GT. de Jong S, et al. Among authors: de vries eg. Br J Cancer. 1991 Feb;63(2):205-12. doi: 10.1038/bjc.1991.50. Br J Cancer. 1991. PMID: 1847646 Free PMC article.

8

Reduced DNA topoisomerase II activity and drug-induced DNA cleavage activity in an adriamycin-resistant human small cell lung carcinoma cell line.

de Jong S, Zijlstra JG, de Vries EG, Mulder NH. de Jong S, et al. Among authors: de vries eg. Cancer Res. 1990 Jan 15;50(2):304-9. Cancer Res. 1990. PMID: 1967222

9

The formation and removal of cisplatin (CDDP) induced DNA adducts in a CDDP sensitive and resistant human small cell lung carcinoma (HSCLC) cell line.

Hospers GA, de Vries EG, Mulder NH. Hospers GA, et al. Among authors: de vries eg. Br J Cancer. 1990 Jan;61(1):79-82. doi: 10.1038/bjc.1990.18. Br J Cancer. 1990. PMID: 2153398 Free PMC article.

10

A study of human small-cell lung carcinoma (hSCLC) cell lines with different sensitivities to detect relevant mechanisms of cisplatin (CDDP) resistance.

Hospers GA, Meijer C, de Leij L, Uges DR, Mulder NH, de Vries EG. Hospers GA, et al. Among authors: de leij l, de vries eg. Int J Cancer. 1990 Jul 15;46(1):138-44. doi: 10.1002/ijc.2910460125. Int J Cancer. 1990. PMID: 2163989

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

983 results

Search Page

Filters